Azitra (AZTR) Operating Leases (2022 - 2026)

Azitra (AZTR) reported Operating Leases of $96740.0 for Q1 2026, down 54.74% on a YoY basis from $213765.0 in Q1 2025, and down 38.06% quarter-over-quarter from $156190.0 in Q4 2025.

Azitra (AZTR) Operating Leases (2022 - 2026) Analysis & Trends

Azitra has reported Operating Leases for 5 years, with the latest figure at $96740.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases fell 54.74% year-over-year to $96740.0; the trailing twelve-month figure through Mar 2026 stood at $96740.0 (down 54.74% YoY), and the FY2025 full-year result was $156190.0, down 43.03% from the prior year.
  • Operating Leases for Q1 2026 stood at $96740.0, down from $156190.0 in the prior quarter.
  • The five-year high for Operating Leases was $991656.0 in Q2 2023, with the low at $96740.0 in Q1 2026.
  • Historically, Operating Leases has averaged $504548.0 across 5 years, with a median of $537523.0 in 2023.
  • The largest YoY upside for Operating Leases was 18.79% in 2025 against a maximum downside of 64.96% in 2025.
  • Azitra's Operating Leases stood at $840896.0 in 2022, then tumbled by 36.08% to $537523.0 in 2023, then plunged by 49.0% to $274161.0 in 2024, then slumped by 43.03% to $156190.0 in 2025, then slumped by 38.06% to $96740.0 in 2026.
  • The last three Operating Leases figures came in at $96740.0 (Q1 2026), $156190.0 (Q4 2025), and $214949.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Azitra 20,900.00 20,900.00 -

Historic Data

Download Data
DateValue
Mar 31, 2026 96,740.00
Dec 31, 2025 156,190.00
Sep 30, 2025 214,949.00
Jun 30, 2025 559,526.00
Mar 31, 2025 213,765.00
Dec 31, 2024 274,161.00
Sep 30, 2024 613,395.00
Jun 30, 2024 689,013.00
Mar 31, 2024 456,315.00
Dec 31, 2023 537,523.00
Sep 30, 2023 914,995.00
Jun 30, 2023 991,656.00
Dec 31, 2022 840,896.00